← Leaderboards
Zaid Abdo
Colorado State University
$1,905,191
Attributed
$4,796,767
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $758.9K · FY2009–24$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$4,796,767 · 4
By mechanism
R01$4,599,454 · 2
P20$197,313 · 2
Top collaborators
- Rodolphe Barrangou7 shared
- Gregg A Dean7 shared
- Eva M. Top3 shared
Most similar at Colorado State University
Same institution · by research overlap
- Gregg A Dean$12,732,502
- Rodolphe Barrangou$1,320,899
- Elizabeth P Ryan$1,684,040
- Donald J Estep$2,326,281
- Thomas Chen$3,619,940
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseProteinsInterestAntibiotic ResistanceAffectVirulenceCold ChainsCrispr/Cas TechnologyDeveloped CountriesAttenuatedClustered Regularly Interspaced Short Palindromic RepeatsAdjuvantClinical TrialsComparative EfficacyCause Of DeathAntibody ResponseCapsid ProteinsCellsAntigensAgonistCessation Of LifeChildAnimalsCapsid
Grant awards (12)
Novel recombinant Rotavirus vaccine utilizing the probiotic microorganism Lactobacillus acidophilus$720,054
R01 · FY2024 · AI
Novel recombinant Rotavirus vaccine utilizing the probiotic microorganism Lactobacillus acidophilus$758,912
R01 · FY2023 · AI
Novel recombinant Rotavirus vaccine utilizing the probiotic microorganism Lactobacillus acidophilus$679,126
R01 · FY2022 · AI
Novel recombinant Rotavirus vaccine utilizing the probiotic microorganism Lactobacillus acidophilus$11,389
R01 · FY2022 · AI
Novel recombinant Rotavirus vaccine utilizing the probiotic microorganism Lactobacillus acidophilus$681,022
R01 · FY2021 · AI
Novel recombinant Rotavirus vaccine utilizing the probiotic microorganism Lactobacillus acidophilus$691,456
R01 · FY2020 · AI
Novel recombinant Rotavirus vaccine utilizing the probiotic microorganism Lactobacillus acidophilus$9,137
R01 · FY2020 · AI
Plasmids as Vectors of Antibiotic Resistance: The Evolution of Plasmid Host-Range$347,636
R01 · FY2012 · AI
Plasmids as Vectors of Antibiotic Resistance: The Evolution of Plasmid Host-Range$348,298
R01 · FY2011 · AI
Plasmids as Vectors of Antibiotic Resistance: The Evolution of Plasmid Host-Range$352,424
R01 · FY2010 · AI
COBRE: UID: PROJ 4: STATISTICAL METHODS FOR THE ANALYSIS OF MICROBIAL COMMUNITY$119,218
P20 · FY2010 · RR · contact PI
COBRE: UID: PROJ 4: STATISTICAL METHODS FOR THE ANALYSIS OF MICROBIAL COMMUNITY$78,095
P20 · FY2009 · RR · contact PI